438
Participants
Start Date
June 2, 2017
Primary Completion Date
December 17, 2018
Study Completion Date
December 17, 2018
Risperidone ISM 75 mg
Monthly (once every 4 weeks) IM injection in the gluteal or deltoid muscle.
Risperidone ISM 100 mg
Monthly (once every 4 weeks) IM injection in the gluteal or deltoid muscle.
Placebo of Risperidone ISM
Monthly (once every 4 weeks) IM injection in the gluteal or deltoid muscle.
CBH Health LLC, Gaithersburg
N.I. Pyrogov Vinnytsya Natl Medical University, Vinnytsia
Carolina Clinical Triasl Inc, Charleston
Atlanta Center for Medical Research, Atlanta
Galiz Research, Hialeah
Innovative Clinical Research Inc., Hollywood
Maltsev Regional Clinical Psychiatric Ho, Poltava
Precise Research Centers MS, Flowood
Midwest Clinical Research Center, Dayton
Regional Clinical Hospital n.a I.I. Mechnicov, Dnipro
Kharkiv Regional Clinical Psychiatric Hospital, Kharkiv
"Public Healthcare Institution Kharkiv Regional Clinical Psychiatric Hospital No. 3, Center of Urgent Psychiatry", Kharkiv
Odesa Regional Medical Centre of Mental Health, Odesa
Woodland Research Northwest, Rogers
Kherson Regional Psychiatric Hospital, Kherson
Pillar Clinical Research LLC, Richardson
InSite Clinical Research, DeSoto
Community Clinical Research Inc., Austin
CI Lviv Regional Clinical Psychiatric Hospital. Department 20, Lviv
CI Lviv Regional Clinical Psychiatric Hospital. Department 25, Lviv
Altea Research Institute, Las Vegas
CNRI-Los Angeles LLC, Pico Rivera
CIMU Bellflower, Cerritos
Apostle Clinical Trials, Long Beach
Synergy Research San Diego, Lemon Grove
CNRI-San Diego, San Diego
Collaborative Neuroscience Network, LLC., Garden Grove
NRC Research Institute, Orange
Hassman Research Institute, Berlin
Kiev City Psychiatric Hospital No. 2, Kiev
"Kyiv Regional Medical Association Psykhiatriya in Kyiv", Kiev
Rovi Pharmaceuticals Laboratories
INDUSTRY